A 58-year-old male with a history of poorly controlled hypertension and diabetes presents with bilateral lower extremity edema and an S4 heart sound. His serum creatinine is elevated at 1.6 mg/dL, and his HbA1c is 8.2%. The clinical team is considering increasing the dosage of Lisinopril and possibly adding a diuretic. What is the primary nursing intervention to prioritize in this patient's care plan to prevent further end-organ damage?

A) Educate the patient on the importance of adhering to a low-sodium diet.

B) Instruct the patient to increase daily fluid intake to promote renal perfusion.

C) Advise the patient to avoid physical activity to prevent elevated blood pressure.

D) Encourage the patient to take over-the-counter NSAIDs for headache management.

A 58-year-old male patient with a history of poorly controlled hypertension and diabetes presents with bilateral lower extremity edema, a faint S4 heart sound, and an elevated serum creatinine level of 1.6 mg/dL. Which of the following nursing interventions is the priority in managing this patient's condition?

B) Educate the patient on the importance of dietary sodium restriction to manage fluid retention.

A) Encourage the patient to increase fluid intake to improve renal function.

B) Educate the patient on the importance of dietary sodium restriction to manage fluid retention.

C) Advise the patient to avoid physical activity to prevent exacerbating his symptoms.

D) Instruct the patient to stop taking Lisinopril until renal function improves.

A patient with hypertension and diabetes is experiencing nocturia and mild dizziness upon standing after an increase in Lisinopril dosage and the addition of a diuretic. The patient's blood pressure is 150/92 mmHg, and serum creatinine is 1.8 mg/dL. Which nursing intervention is the priority to address the patient's symptoms and improve health outcomes?

B) Instruct the patient to rise slowly from a sitting or lying position to prevent dizziness.

A) Educate the patient on the importance of taking medications at the same time each day to improve adherence.

B) Instruct the patient to rise slowly from a sitting or lying position to prevent dizziness.

C) Advise the patient to increase fluid intake to compensate for fluid loss from nocturia.

D) Encourage the patient to consume a high-protein diet to support renal function.

A patient with hypertension and diabetes has been on Lisinopril and a diuretic but presents with a blood pressure of 150/92 mmHg, nocturia, and mild dizziness upon standing. Lab results indicate microalbuminuria and a serum creatinine level of 1.8 mg/dL. The clinical team is considering a switch to a calcium channel blocker. What is the most important consideration for the nurse when monitoring this patient's response to the new antihypertensive medication?

C) Assess for improvements in renal function by monitoring serum creatinine levels regularly.

A) Monitor for signs of peripheral edema and adjust the medication dosage accordingly.

B) Educate the patient on increasing fluid intake to offset potential orthostatic hypotension.

C) Assess for improvements in renal function by monitoring serum creatinine levels regularly.

D) Encourage the patient to reduce physical activity to prevent cardiac complications.

A patient with hypertension and diabetes mellitus type 2 is undergoing medication adjustments to improve cardiovascular risk factors. The healthcare team decides to discontinue a diuretic and introduce a calcium channel blocker while starting a statin. What is the most critical nursing intervention to prioritize during this transition?

D) Assess the patient for orthostatic hypotension during position changes.

A) Educate the patient on the importance of adhering to a low-sodium diet.

B) Monitor the patient for signs of muscle pain or weakness.

C) Instruct the patient to increase fluid intake to prevent dehydration.

D) Assess the patient for orthostatic hypotension during position changes.

A patient with hypertension, elevated LDL cholesterol, and diabetes mellitus has been transitioned from a diuretic to a calcium channel blocker and started on a statin. Which nursing intervention is most appropriate to address the patient's risk of orthostatic hypotension and ensure proper management of his condition?

A) Instruct the patient to monitor his blood pressure while lying, sitting, and standing, and report any significant changes.

B) Educate the patient on the importance of increasing sodium intake to maintain blood pressure levels.

C) Advise the patient to take his calcium channel blocker and statin first thing in the morning to maximize effectiveness.

D) Encourage the patient to avoid all physical activity until his follow-up appointment to prevent dizziness.

A patient recently started on calcium channel blocker and statin therapy reports mild ankle swelling at a follow-up visit. The healthcare team decides to add an ACE inhibitor to the regimen. Which nursing intervention is most appropriate to address the patient’s ankle swelling?

B) Instruct the patient to limit salt intake and elevate legs periodically.

A) Educate the patient on increasing fluid intake to reduce swelling.

B) Instruct the patient to limit salt intake and elevate legs periodically.

C) Advise the patient to wear compression stockings during the day.

D) Recommend the patient engage in regular high-intensity exercise.

A patient with hypertension, hyperlipidemia, and type 2 diabetes is on a calcium channel blocker, statin, and is being considered for an ACE inhibitor addition due to renal concerns. What is the primary nursing intervention to address the patient's current renal status?

C) Educate the patient on the importance of adhering to dietary sodium restrictions.

A) Encourage increased fluid intake to prevent dehydration.

B) Monitor blood pressure and instruct the patient to report any significant changes.

C) Educate the patient on the importance of adhering to dietary sodium restrictions.

D) Schedule daily weight checks to monitor for fluid retention.

A patient taking an ACE inhibitor presents with a serum potassium level of 5.2 mmol/L. The nurse is reviewing dietary education with the patient to manage this condition. Which statement by the patient indicates a need for further teaching?

C) 'I can continue to eat spinach and potatoes as they are healthy vegetables.'

A) 'I will limit my intake of bananas and oranges to reduce my potassium levels.'

B) 'I should avoid using salt substitutes that contain potassium chloride.'

C) 'I can continue to eat spinach and potatoes as they are healthy vegetables.'

D) 'I will monitor my blood pressure and report any significant changes to my healthcare provider.'

A patient with hypertension and diabetes is being treated with an ACE inhibitor and presents with mild hyperkalemia at a follow-up appointment. Which nursing intervention is most appropriate to address this lab finding while maintaining the patient's current treatment regimen?

B) Educate the patient on reducing high-potassium foods such as tomatoes and spinach.

A) Suggest the patient increase dietary intake of bananas and oranges to balance electrolytes.

B) Educate the patient on reducing high-potassium foods such as tomatoes and spinach.

C) Advise the patient to discontinue the ACE inhibitor until potassium levels normalize.

D) Recommend the patient start a potassium-sparing diuretic to counteract hyperkalemia.

Hypertension - Nursing Case Study

Pathophysiology

• Primary mechanism: Increased peripheral resistance - Hypertension often results from narrowed or stiffened blood vessels, primarily due to factors like atherosclerosis, leading to elevated systemic vascular resistance and increased blood pressure to maintain adequate tissue perfusion.

• Secondary mechanism: Enhanced sympathetic nervous system activity - Overactivity of the sympathetic nervous system can increase heart rate and contractility, as well as cause vasoconstriction, further elevating blood pressure.

• Key complication: Left ventricular hypertrophy - Persistent high blood pressure forces the heart to work harder to pump blood, resulting in thickening of the heart muscle, which can lead to heart failure and other cardiovascular complications.

Patient Profile

Demographics:

58-year-old male, construction worker

History:

• Key past medical history: Hypertension diagnosed 5 years ago, type 2 diabetes, obesity

• Current medications: Lisinopril 20 mg daily, Metformin 500 mg twice daily, Aspirin 81 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent headaches and occasional dizziness

• Key symptoms: Fatigue, shortness of breath on exertion, mild chest discomfort

• Vital signs: Blood pressure 160/100 mmHg, heart rate 88 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F, BMI 32

Section 1

As the clinical team conducts an initial assessment of the 58-year-old male patient, several critical findings are noted. The patient's physical examination reveals bilateral lower extremity edema, suggesting possible fluid retention. Auscultation of the chest uncovers a faint S4 heart sound, indicative of left ventricular hypertrophy, which aligns with the patient's history of poorly controlled hypertension. The patient also reports experiencing increased frequency and severity of headaches, which raises concerns about potential end-organ damage due to sustained elevated blood pressure.

Laboratory investigations are ordered to gain a clearer picture of the patient's condition. The results reveal elevated serum creatinine levels of 1.6 mg/dL, indicating a decline in renal function, likely secondary to chronic hypertension and diabetes. Additionally, the patient's HbA1c is found to be 8.2%, suggesting suboptimal glycemic control. An electrocardiogram shows signs of left ventricular hypertrophy, supporting the physical exam findings and emphasizing the need for more aggressive management of the patient's hypertension and diabetes.

Faced with these findings, the clinical team discusses potential changes to the patient's management plan. There is consideration of increasing the dosage of Lisinopril to better control blood pressure and protect renal function. Further, the addition of a diuretic may be warranted to manage fluid retention and help reduce blood pressure. The team also contemplates reinforcing lifestyle modifications, such as dietary changes and increased physical activity, to address obesity and improve overall cardiovascular health. The patient is advised to monitor blood pressure and blood glucose levels more frequently to detect any further changes in his condition promptly. These steps are crucial in averting progression to more severe complications, such as heart failure or significant renal impairment.

Section 2

As the clinical team implements the adjusted management plan, the patient is carefully monitored for changes in his status. Within a week, the patient returns for a follow-up appointment, at which point a reevaluation is conducted. The patient's vital signs indicate a blood pressure reading of 150/92 mmHg, which, although improved, remains above the target range. The patient's weight has decreased by 2 kg, suggesting some success in managing fluid retention. However, the patient reports continuing episodes of nocturia and mild dizziness upon standing, which raises concerns about possible orthostatic hypotension from the increased Lisinopril dosage and the addition of a diuretic.

Further laboratory tests reveal that the serum creatinine level has increased slightly to 1.8 mg/dL, indicating no significant improvement in renal function despite therapeutic adjustments. Additionally, a new laboratory finding of microalbuminuria is noted, underscoring the impact of hypertension and diabetes on renal health. The patient's HbA1c remains at 8.0%, reflecting only marginal improvement in glycemic control. An echocardiogram is performed, confirming persistent left ventricular hypertrophy and raising the importance of strict blood pressure management to prevent further cardiac complications.

In response to these findings, the clinical team reconsiders the patient's current pharmacologic regimen and lifestyle interventions. There is a discussion about switching to a different class of antihypertensive medications, such as a calcium channel blocker, which might offer better blood pressure control without exacerbating renal issues. Additionally, the team emphasizes the importance of continued dietary modifications, particularly focusing on reducing sodium intake, and encourages the patient to gradually increase physical activity as tolerated. These steps aim to enhance the patient's cardiovascular and renal outcomes, with the goal of preventing progression to more severe complications like heart failure or advanced kidney disease. The patient is scheduled for more frequent follow-up appointments to closely monitor his response to these changes and to adjust the management plan as needed.

Section 3

Two weeks following the adjustment of his treatment plan, the patient returns for another follow-up appointment. Throughout this period, he has adhered to dietary changes and increased his physical activity, albeit cautiously due to his episodes of dizziness. During the initial assessment, the patient's blood pressure is recorded at 142/88 mmHg, showing modest improvement but still not within the optimal range. Notably, his heart rate is 78 beats per minute, and he reports fewer episodes of dizziness, suggesting some adaptation to the medication adjustments. The nocturia persists, though slightly reduced, indicating a need for continued monitoring and possible further intervention.

New laboratory results present a mixed picture. The serum creatinine level has stabilized at 1.8 mg/dL, with no further deterioration, but the microalbuminuria persists, confirming ongoing renal stress. The patient's lipid profile reveals elevated LDL cholesterol at 130 mg/dL, an increase from previous results, which may necessitate the consideration of a statin to address potential atherosclerotic risk. Moreover, the patient's HbA1c has decreased to 7.8%, reflecting slight improvement in glycemic control, yet still indicating the necessity for more aggressive diabetes management.

Given these findings, the clinical team recognizes the importance of a more comprehensive cardiovascular risk management strategy. They decide to transition the patient to a calcium channel blocker, discontinuing the diuretic to reduce the risk of orthostatic hypotension while potentially offering better blood pressure control. The team also integrates a statin into his regimen, aiming to tackle the newly elevated cholesterol levels. Education on lifestyle modifications is reinforced, focusing on sustained physical activity and a heart-healthy diet low in sodium and saturated fats. The patient is urged to self-monitor his blood pressure at home and to report any new symptoms promptly, with a follow-up appointment scheduled in four weeks to assess the efficacy of these interventions and to make further adjustments as needed.

Section 4

Two weeks after the initiation of the calcium channel blocker and statin therapy, the patient returns for his scheduled follow-up appointment. Upon initial assessment, his blood pressure has decreased to 136/82 mmHg, indicating a positive response to the new antihypertensive regimen. His heart rate remains steady at 76 beats per minute. The patient reports a significant reduction in dizziness and has been able to engage more vigorously in physical activities, suggesting improved tolerance to the medication changes. However, he mentions experiencing mild swelling in his ankles, which may be a side effect of the calcium channel blocker, warranting further evaluation and management.

The new laboratory results present a mixed scenario. The patient's LDL cholesterol has decreased to 110 mg/dL, demonstrating an effective response to the statin therapy. However, microalbuminuria persists, and the serum creatinine has slightly increased to 1.9 mg/dL, raising concerns about ongoing renal stress. Additionally, his HbA1c has slightly improved to 7.5%, reflecting better glycemic control, yet still highlighting the need for continued diabetes management. These findings suggest the necessity of ongoing monitoring and possibly further adjustments in his treatment plan to address renal function and optimize cardiovascular risk reduction.

The clinical team decides to continue with the current antihypertensive and statin therapy but considers adding an ACE inhibitor to provide renal protection and further improve blood pressure control. The patient is counseled on reducing fluid retention through dietary modifications, such as limiting salt intake, and is advised to elevate his legs periodically to manage the peripheral edema. The plan includes frequent monitoring of renal function and electrolytes, with another follow-up appointment scheduled in four weeks. This interval will allow the team to assess the impact of the ACE inhibitor addition and make any necessary adjustments to his management plan based on his renal function and overall cardiovascular risk profile.

Section 5

Four weeks later, the patient returns for his follow-up appointment. During the initial assessment, the nurse notes that the patient’s blood pressure has further decreased to 128/80 mmHg, indicating a positive response to the addition of the ACE inhibitor. His heart rate remains stable at 74 beats per minute. The patient reports that the swelling in his ankles has diminished significantly following the dietary modifications and leg elevation practices. He also mentions feeling less fatigued and more capable of carrying out daily activities without discomfort, suggesting an overall improvement in his condition.

New laboratory results, however, reveal that while his serum creatinine has stabilized at 1.8 mg/dL, indicating no further renal deterioration, there is a new concern. His potassium level has risen to 5.2 mmol/L, suggesting mild hyperkalemia, a potential side effect of ACE inhibitor therapy. The microalbuminuria persists, albeit at a slightly reduced level, but his HbA1c has further improved to 7.3%, underscoring the effectiveness of current diabetes management strategies. The team recognizes the importance of addressing the hyperkalemia to prevent complications while continuing to monitor renal function closely.

In response to these findings, the clinical team decides to maintain the current antihypertensive regimen but advises the patient on dietary adjustments to manage his potassium levels, such as limiting high-potassium foods. They stress the importance of adherence to the low-sodium diet and plan to recheck his electrolytes and renal function in two weeks. The ongoing management will focus on balancing the benefits of ACE inhibitor therapy for renal protection with the potential risk of hyperkalemia, ensuring that the patient's overall cardiovascular and renal health is optimized.